Bayer CropScience Ltd
NSE: BAYERCROP BSE: 506285Chemicals
Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
₹4,308
52W: ₹4273 — ₹6540
PE 28.8 · Book ₹695 · +520% vs bookMarket Cap₹19,361 Cr
Stock P/E28.8Price to Earnings
ROCE24.8%Return on Capital
ROE20%Return on Equity
Div. Yield2.91%Face Value ₹10
Strengths
- +Company is almost debt free.
- +Company has been maintaining a healthy dividend payout of 86.9%
Weaknesses
- −The company has delivered a poor sales growth of 8.68% over past five years.
Shareholding Pattern
Promoters71.44%
FIIs3.89%
DIIs11.89%
Public12.79%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% |
| FIIs | 3.63% | 3.3%▼0.3 | 3.42%▲0.1 | 3.49%▲0.1 | 3.64%▲0.1 | 3.8%▲0.2 | 3.84%▲0.0 | 3.89%▲0.1 |
| DIIs | 12.47% | 12.08%▼0.4 | 11.69%▼0.4 | 11.56%▼0.1 | 11.38%▼0.2 | 11.22%▼0.2 | 11.47%▲0.3 | 11.89%▲0.4 |
| Public | 12.47% | 13.18%▲0.7 | 13.45%▲0.3 | 13.53%▲0.1 | 13.55%▲0.0 | 13.56%▲0.0 | 13.27%▼0.3 | 12.79%▼0.5 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,617 | 955 | 792 | 1,631 | 1,738 | 1,057 | 1,046 | 1,915 | 1,553 | 1,106 |
| Expenses | 1,312 | 827 | 695 | 1,317 | 1,554 | 1,037 | 876 | 1,566 | 1,348 | 989 |
| Operating Profit | 305 | 128 | 97 | 314 | 184 | 20 | 171 | 348 | 205 | 117 |
| OPM % | 19% | 13% | 12% | 19% | 11% | 2% | 16% | 18% | 13% | 11% |
| Net Profit | 223 | 93 | 96 | 254 | 136 | 34 | 143 | 279 | 153 | 96 |
| EPS ₹ | 49.6 | 20.72 | 21.36 | 56.56 | 30.33 | 7.61 | 31.89 | 62.01 | 33.98 | 21.29 |
AI Insights
Revenue Trend
TTM revenue at ₹5,621Cr, up 2.7% YoY. OPM at 15%.
Debt Position
Borrowings at ₹102Cr. Debt-to-equity ratio: 0.03x. Healthy balance sheet.
Capex Cycle
CWIP at ₹9Cr (2% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 11.89% (-1.17pp change). FIIs: 3.89% (+0.71pp change). Promoters hold 71.44%.
Margin & Efficiency
ROCE improving from 24% (Mar 2014) to 25% (Mar 2025). Working capital days: 88.
Valuation
PE 28.8x with 24.8% ROCE. Price is 520% above book value of ₹695. Dividend yield: 2.91%.
Recent Announcements
- Intimation To Holders Of Physical Securities To Furnish PAN, KYC Details And Nomination As Per The Applicable SEBI Circulars 14 May - Bayer CropScience asks physical shareholders to update PAN, KYC and nomination details.
- Board Meeting Intimation for The Quarter And Financial Year Ended March 31, 2026. 11 May - Board meets May 26, 2026 for audited FY26 results and possible final dividend.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 5 May - Pursuant to Regulation 30 and 47 read with Schedule III Part A Para A of SEBI LODR Regulations, 2015, we hereby enclose newspaper advertisements published …
- Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Apr - Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, enclosed herewith copies of newspaper advertisement regarding relaunch of 100 days Campaign by IEPF. This is …
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Attached the Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse